Cytokinetics (CYTK) Net Margin (2016 - 2024)
Historic Net Margin for Cytokinetics (CYTK) over the last 16 years, with Q4 2024 value amounting to 1655.61%.
- Cytokinetics' Net Margin rose 97047700.0% to 1655.61% in Q4 2024 from the same period last year, while for Dec 2024 it was 7765.51%, marking a year-over-year increase of 147311300.0%. This contributed to the annual value of 1522.37% for FY2024, which is 84879900.0% up from last year.
- As of Q4 2024, Cytokinetics' Net Margin stood at 1655.61%, which was up 97047700.0% from 32338.88% recorded in Q3 2024.
- In the past 5 years, Cytokinetics' Net Margin ranged from a high of 1655.61% in Q4 2024 and a low of 57391.16% during Q2 2024
- Its 5-year average for Net Margin is 9414.31%, with a median of 2459.95% in 2021.
- The largest annual percentage gain for Cytokinetics' Net Margin in the last 5 years was 97047700bps (2024), contrasted with its biggest fall of -425014300bps (2024).
- Over the past 5 years, Cytokinetics' Net Margin (Quarter) stood at 320.68% in 2020, then crashed by -120bps to 64.69% in 2021, then plummeted by -10492bps to 6851.66% in 2022, then dropped by -17bps to 8049.16% in 2023, then skyrocketed by 121bps to 1655.61% in 2024.
- Its Net Margin was 1655.61% in Q4 2024, compared to 32338.88% in Q3 2024 and 57391.16% in Q2 2024.